Massive parallel sequencing (NGS) is useful in detecting and later classifying somatic driver mutations in cancer tumours. False-positive variants occur in the NGS workflow and they may be mistaken for low frequency somatic cancer mutations in a patient sample. This pushes the need for decreasing the noise rate in the NGS workflow since it may improve the detection of rare allele frequency variants, in particular cancer mutations. In this project, the aim was to reduce the level of false-positive variants in an NGS workflow. The scope was limited to looking at substitution errors and their neighbouring nucleotides. Alongside this, it was also a way to understand how different types of substitution errors are distributed in the data, if thei...
The study of rare variants in next generation sequencing (NGS) experiments enables the detection of ...
Introduction: Variant detection protocols for clinical next-generation sequencing (NGS) need applica...
Introduction: Use of next-generation sequencing (NGS) has seen a dramatic expansion in the clinical ...
Massive parallel sequencing (NGS) is useful in detecting and later classifying somatic driver mutati...
The accurate detection of ultralow allele frequency variants in DNA samples is of interest in both r...
Next-generation sequencing (NGS) has enabled the high-throughput discovery of germline and somatic m...
Next-generation sequencing (NGS) is becoming a common approach for clinical testing of oncology spec...
Next-generation sequencing (NGS) has revolutionized genetics and enabled the accurate identification...
Next-generation sequencing (NGS) has enabled the high-throughput discovery of germline and somatic m...
Next-generation sequencing (NGS) technology has improved enough to discover mutations associated wit...
Next-generation sequencing (NGS) has revolutionized genetics and enabled the accurate identification...
Cancer, which affects hundreds of thousands of people worldwide every year and costs billions in tre...
Abstract Background Sequencing errors are key confounding factors for detecting low-frequency geneti...
The accuracy of next-generation sequencing (NGS) for detecting tumor-specific mutations in plasma DN...
Rapid development of Next Generation Sequencing (NGS) technology has substantially transformed the l...
The study of rare variants in next generation sequencing (NGS) experiments enables the detection of ...
Introduction: Variant detection protocols for clinical next-generation sequencing (NGS) need applica...
Introduction: Use of next-generation sequencing (NGS) has seen a dramatic expansion in the clinical ...
Massive parallel sequencing (NGS) is useful in detecting and later classifying somatic driver mutati...
The accurate detection of ultralow allele frequency variants in DNA samples is of interest in both r...
Next-generation sequencing (NGS) has enabled the high-throughput discovery of germline and somatic m...
Next-generation sequencing (NGS) is becoming a common approach for clinical testing of oncology spec...
Next-generation sequencing (NGS) has revolutionized genetics and enabled the accurate identification...
Next-generation sequencing (NGS) has enabled the high-throughput discovery of germline and somatic m...
Next-generation sequencing (NGS) technology has improved enough to discover mutations associated wit...
Next-generation sequencing (NGS) has revolutionized genetics and enabled the accurate identification...
Cancer, which affects hundreds of thousands of people worldwide every year and costs billions in tre...
Abstract Background Sequencing errors are key confounding factors for detecting low-frequency geneti...
The accuracy of next-generation sequencing (NGS) for detecting tumor-specific mutations in plasma DN...
Rapid development of Next Generation Sequencing (NGS) technology has substantially transformed the l...
The study of rare variants in next generation sequencing (NGS) experiments enables the detection of ...
Introduction: Variant detection protocols for clinical next-generation sequencing (NGS) need applica...
Introduction: Use of next-generation sequencing (NGS) has seen a dramatic expansion in the clinical ...